![](/img/cover-not-exists.png)
Adjuvant capecitabine in biliary tract cancer: a standard option?
Malka, David, Edeline, JulienLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(19)30022-1
Date:
March, 2019
File:
PDF, 213 KB
english, 2019